National Institute of Environmental Health Sciences   —  National Institutes of Health   —  U.S. Department of Health and Human Services

The Sister Study

CANCERS DATA COLLECTION

Confirmation of Breast Cancer Diagnosis

(Links on this page require Adobe Acrobat - Download Here) exit disclaimer

Information on incident breast cancer and other health conditions is collected via the Annual Health Updates, the Detailed Follow-Up Questionnaires, and through telephone calls, e-mails, or correspondence with the Sister Study Helpdesk. Approximately six months after the reported date of a cancer diagnosis, participants are asked for permission to contact their health provider for pathology reports or other diagnostic documentation (cancers other than breast) or more complete medical records (breast cancer). Participants may choose to send these documents to the Sister Study in lieu of signing the authorization form to contact their health provider. This medical documentation is abstracted (Breast Cancer Medical Report Form, and when applicable, Stage IV Breast Cancer Medical Report Form; Other Cancer Medical Report Form) for verification of self-reported diagnoses and used in analysis of specific subtypes and treatments (breast cancer only). More detailed medical records may be requested for specific nested studies. Tissue blocks and slides are also requested for breast, ovarian, fallopian tube, and peritoneal cancer diagnoses. Additionally, women that report a breast cancer diagnosis are asked to complete a Breast Cancer Follow-Up Form (BCFF) by mail or respond by telephone (CATI). Topics covered by the BCFF are summarized below.

Breast Cancer Follow Up and Medical Records Report Forms

Links to all versions of the Breast Cancer Follow-Up (BCFF) questionnaires and Medical Record Report Forms can be found in the table below. For a summary of changes to each BCFF version, please click here. We are currently in the process of making these documents Section 508 compliant. If you need assistance before then please click here to contact us.

Abbre-
viation
Title Description
CA

Breast Cancer Follow-Up Version 1 CATI
(PDF 146 KB)

Breast Cancer Follow-Up Version 2 CATI
(PDF 134 KB)

Breast Cancer Follow-Up Version 3 CATI and Mail
(PDF 43 KB)

Breast Cancer Follow-Up Version 4 CATI and Mail
(PDF 66 KB)

  Covers these major topics:

  • Verification of previously reported diagnosis information (e.g. diagnosis date, invasiveness, ductal or lobular origin)
  • Lymph nodes and metastases
  • Treatment (surgery, chemotherapy, radiation therapy, other treatments and clinical trial participation)
  • Psychosocial factors
MRF

Breast Cancer Medical Report Forms

All breast cancer
:
(PDF 125 KB)

Stage IV breast cancer: (PDF 59 KB)


Medical Report Form Archive

Used by medical record abstraction staff to record data obtained from medical records and pathology reports received from women reporting breast cancer and their health care providers, collect information needed for staging, and obtain additional diagnostic information. Information abstracted includes: 

  • Tumor characteristics
  • Hormone receptor status
  • Lymph node involvement
  • Metastasis
  • Treatments (surgery, chemotherapy, radiation, biological therapy, hormonal treatment, clinical trial enrollment)
  • Genetic testing

Other Cancer Medical Report Form

Link to the Medical Report Form can be found in the table below. We are currently in the process of making this document Section 508 compliant. If you need assistance before then please click here to contact us.

Abbre-
viation
Title Description
OX

Other Cancer Medical Report Form
(PDF 88 KB)

Used by medical record abstraction staff to record data obtained from pathology reports and other diagnostic documents received from women reporting cancer cases other than breast or non-melanoma skin and/or their health care providers. The information is used to validate the self-reported diagnosis, collect information on cancer type and stage, and to obtain additional diagnostic information. Information abstracted includes:

  • Tumor characteristics
  • Lymph node involvement
  • Metastasis

 

 


About NIH/NIEHS    |   Accessibility    |    Contact Us    |    Disclaimersexit disclaimer    |    Freedom of Information Actexit disclaimer    |    Office of Inspector General (OIG)exit disclaimer    |    Privacy Policy    |    Vulnerability Disclosure Policyexit disclaimer    |    Website Archiveexit disclaimer